Literature DB >> 9459369

Urinary, plasma, and erythrocyte carnitine concentrations during transition to a lactoovovegetarian diet with vitamin B-6 depletion and repletion in young adult women.

W Chen1, Y C Huang, T D Shultz, M E Mitchell.   

Abstract

The purpose of the present study was to determine whether vitamin B-6 depletion and repletion influence carnitine concentrations in the plasma, erythrocytes, and urine of young adult women consuming a low-carnitine (30 micromol/d), lactoovovegetarian diet. Doses of vitamin B-6 were administered sequentially as follows: 1.60 mg/d during adjustment for 9 d, 0.46 mg/d during depletion for 27 d, 1.26 mg/d during the first repletion for 21 d, 1.66 mg/d during the second repletion for 21 d, and 2.06 mg/d during the third repletion for 14 d. Urinary carnitine tended to decline but was not significantly different throughout the 92-d study period. Plasma short-chain acylcarnitine and total carnitine decreased during vitamin B-6 depletion; however, the ratio of plasma acylcarnitine to total carnitine was not significantly different during changes in vitamin B-6 intake. Erythrocyte long-chain acylcarnitine increased during vitamin B-6 depletion, but the ratio of erythrocyte acylcarnitine to total carnitine did not respond to changes in vitamin B-6 intake. Plasma free and total carnitine concentrations were only weakly correlated with plasma pyridoxal-P concentration (r = 0.28 and r = 0.29, respectively; P < 0.01). No significant correlations were observed between urinary carnitine excretion or erythrocyte carnitine concentrations and plasma or erythrocyte pyridoxal-P concentrations. Thus, a vitamin B-6 intake of 0.5 mg/d does not affect carnitine concentrations in biological fluids and therefore is unlikely to affect endogenous carnitine synthesis over 27 d. The changes in carnitine indexes that we observed were probably due to adaptation to a vegetarian pattern of exogenous carnitine consumption.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9459369     DOI: 10.1093/ajcn/67.2.221

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  5 in total

1.  Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.

Authors:  Hiroshi Deguchi; Yajnavalka Banerjee; Sunia Trauger; Gary Siuzdak; Ewa Kalisiak; José A Fernández; Linh Hoang; Minerva Tran; Subramanian Yegneswaran; Darlene J Elias; John H Griffin
Journal:  Blood       Date:  2015-07-14       Impact factor: 22.113

2.  The effect of L-carnitine in the prevention of ionizing radiation-induced cataracts: a rat model.

Authors:  Ibrahim Kocer; Seyithan Taysi; Mustafa Vecdi Ertekin; Ihsan Karslioglu; Akcahan Gepdiremen; Orhan Sezen; Korkmaz Serifoglu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-17       Impact factor: 3.117

3.  Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.

Authors:  Hiroshi Deguchi; Darlene J Elias; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20

4.  Correlation of Serum Free Carnitine with Serum Ferritin and Vitamin C Levels in Type II Diabetic Men.

Authors:  Ahmad Pourabbas; Farnoush Fallah; Reza Mahdavi; Akbar Aliasgarzadeh
Journal:  Iran J Public Health       Date:  2013-07-01       Impact factor: 1.429

5.  Impaired acylcarnitine profile in transfusion-dependent beta-thalassemia major patients in Bangladesh.

Authors:  Suprovath Kumar Sarker; Md Tarikul Islam; Golam Sarower Bhuyan; Nusrat Sultana; Mst Noorjahan Begum; Mohammad Al Mahmud-Un-Nabi; Md Abdulla Al Noman Howladar; Tashmim Farhana Dipta; A K M Muraduzzaman; Syeda Kashfi Qadri; Tahmina Shirin; Salma Sadiya; Manzoor Hussain; Waqar Ahmed Khan; Sharif Akhteruzzaman; Syed Saleheen Qadri; Firdausi Qadri; Kaiissar Mannoor
Journal:  J Adv Res       Date:  2018-04-25       Impact factor: 10.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.